CDMO Partner Programs

About The Ritedose Corporation

The Ritedose Corporation, founded in 1995 and headquartered in Columbia, South Carolina, has established itself as the largest CDMO specializing in sterile Blow-Fill-Seal (BFS) technology in the United States. The company operates a dual business model, providing high-speed, scalable contract manufacturing services to partners while also producing and distributing a portfolio of generic pharmaceuticals, notably claiming the largest nebulized drug portfolio in the U.S. With a production capacity of over 1.8 billion doses annually from a 100,000+ square-foot facility, Ritedose is a critical player in ensuring a stable supply of essential, sterile unit-dose medications and addressing drug shortages.

Therapeutic Areas